Mien-Chie Hung Selected Research

Mien-Chie Hung Research Topics

Disease

322	Neoplasms (Cancer) 03/2024 - 01/2002
141	Breast Neoplasms (Breast Cancer) 03/2024 - 02/2002
67	Neoplasm Metastasis (Metastasis) 03/2024 - 01/2002
42	Carcinogenesis 01/2021 - 06/2002
31	Triple Negative Breast Neoplasms 09/2023 - 09/2009
20	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 11/2002
17	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 03/2002
14	Lung Neoplasms (Lung Cancer) 01/2023 - 11/2004
13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 01/2011
13	Adenocarcinoma 01/2022 - 06/2007
13	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 07/2003
13	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 03/2003
12	Infections 11/2023 - 10/2002
12	COVID-19 11/2023 - 01/2020
11	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 11/2002
9	Hypoxia (Hypoxemia) 01/2021 - 04/2005
7	Esophageal Neoplasms (Esophageal Cancer) 12/2015 - 06/2007
6	Melanoma (Melanoma, Malignant) 01/2023 - 01/2002
6	Glioblastoma (Glioblastoma Multiforme) 12/2019 - 02/2009
6	Colonic Neoplasms (Colon Cancer) 01/2018 - 10/2002
5	Inflammation (Inflammations) 01/2023 - 08/2007
4	Squamous Cell Carcinoma of Head and Neck 03/2024 - 01/2015
4	Disease Progression 01/2024 - 05/2006
4	Bites and Stings (Sting) 01/2023 - 01/2022
4	Obesity 01/2023 - 11/2008

Drug/Important Bio-Agent (IBA)

82	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2002
44	Phosphotransferases (Kinase)IBA 04/2024 - 02/2002
30	ErbB Receptors (EGF Receptor)IBA 01/2023 - 02/2002
22	Immune Checkpoint InhibitorsIBA 02/2024 - 07/2017
22	Biomarkers (Surrogate Marker)IBA 12/2023 - 06/2004
21	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 11/2002
19	Tyrosine Kinase InhibitorsIBA 10/2023 - 11/2009
18	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2024 - 11/2004
17	LigandsIBA 03/2024 - 08/2002
16	Transcription Factors (Transcription Factor)IBA 01/2020 - 10/2002
15	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2024 - 02/2016
15	MicroRNAs (MicroRNA)IBA 01/2018 - 06/2010
14	Trastuzumab (Herceptin)FDA Link 07/2014 - 10/2002
12	B7-H1 AntigenIBA 05/2023 - 10/2017
12	Monoclonal AntibodiesIBA 10/2022 - 10/2002
11	Tyrosine (L-Tyrosine)FDA Link 01/2019 - 02/2002
11	Epidermal Growth Factor (EGF)IBA 12/2018 - 11/2006
11	Liposomes (Liposome)IBA 01/2015 - 11/2002
10	Long Noncoding RNAIBA 01/2023 - 11/2014
10	Cadherins (E-Cadherin)IBA 01/2022 - 06/2005
10	Hormones (Hormone)IBA 01/2021 - 01/2004
10	Small Interfering RNA (siRNA)IBA 04/2018 - 05/2007
10	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 10/2002
9	Ribonucleases (Ribonuclease)IBA 02/2024 - 09/2012
9	RNA (Ribonucleic Acid)IBA 01/2023 - 02/2002
9	CytokinesIBA 01/2021 - 11/2008
8	Estrogen ReceptorsIBA 01/2023 - 06/2009
8	Messenger RNA (mRNA)IBA 01/2023 - 10/2005
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 08/2011
8	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 05/2008
8	LuciferasesIBA 11/2019 - 03/2004
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2016 - 10/2002
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016 - 08/2007
7	Immune Checkpoint ProteinsIBA 03/2024 - 01/2018
7	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2023 - 10/2003
7	AntibodiesIBA 05/2023 - 04/2004
7	Sirolimus (Rapamycin)FDA Link 01/2017 - 02/2004
7	Histones (Histone)IBA 08/2016 - 09/2008
7	NF-kappa B (NF-kB)IBA 04/2012 - 10/2002
7	beta CateninIBA 02/2009 - 10/2002
6	LipidsIBA 05/2024 - 07/2002
6	Interleukin-6 (Interleukin 6)IBA 01/2023 - 09/2011
6	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 06/2014
6	Cetuximab (Erbitux)FDA Link 01/2022 - 12/2015
6	tyrosine receptor (receptor, tyrosine)IBA 06/2021 - 11/2009
6	human ERBB2 proteinIBA 01/2021 - 04/2013
6	Peptides (Polypeptides)IBA 01/2021 - 10/2002
5	Gemcitabine FDA Link 01/2024 - 10/2003
5	Therapeutic UsesIBA 01/2023 - 09/2004
5	EnzymesIBA 01/2023 - 06/2009
5	ChromatinIBA 01/2023 - 05/2007
5	Programmed Cell Death 1 ReceptorIBA 01/2022 - 12/2018
5	Phenobarbital (Luminal)FDA Link 01/2022 - 01/2019
5	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 09/2010
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 11/2009
5	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2018 - 05/2012
5	TOR Serine-Threonine KinasesIBA 02/2010 - 10/2004
5	I-kappa B KinaseIBA 10/2009 - 04/2004
5	Glycogen Synthase Kinase 3 betaIBA 02/2009 - 06/2005
4	Angiotensin-Converting Enzyme 2IBA 11/2023 - 06/2021
4	InterferonsIBA 01/2023 - 10/2008
4	Chemokine ReceptorsIBA 01/2023 - 11/2004
4	AntigensIBA 10/2022 - 03/2011
4	ParaffinIBA 01/2022 - 08/2011
4	Protein Isoforms (Isoforms)IBA 01/2022 - 05/2007
4	Formaldehyde (Formol)FDA Link 01/2022 - 05/2010
4	Polysaccharides (Glycans)IBA 01/2022 - 08/2011
4	Arginine (L-Arginine)FDA Link 01/2021 - 09/2015
4	AndrogensIBA 01/2020 - 03/2005
4	Endoplasmic Reticulum Chaperone BiPIBA 01/2020 - 11/2014
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 02/2006

Therapy/Procedure

121	Therapeutics 03/2024 - 11/2002
32	Immunotherapy 03/2024 - 10/2017
31	Drug Therapy (Chemotherapy) 01/2024 - 10/2003
6	Radiotherapy 10/2022 - 09/2011